

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine biosynthetic process (GO:0045080) | 6.30394361 |
| 2 | cytidine deamination (GO:0009972) | 6.23224216 |
| 3 | cytidine metabolic process (GO:0046087) | 6.23224216 |
| 4 | cytidine catabolic process (GO:0006216) | 6.23224216 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.13798163 |
| 6 | DNA deamination (GO:0045006) | 5.67649015 |
| 7 | response to peptidoglycan (GO:0032494) | 5.64765600 |
| 8 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.50848338 |
| 9 | regulation of chemokine biosynthetic process (GO:0045073) | 5.30022525 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.24087179 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.24087179 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.24087179 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.24087179 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.24087179 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 5.24087179 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 5.18158333 |
| 17 | cellular response to exogenous dsRNA (GO:0071360) | 5.13128400 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.95645547 |
| 19 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.81966452 |
| 20 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 4.70803740 |
| 21 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 4.70803740 |
| 22 | eosinophil chemotaxis (GO:0048245) | 4.68024190 |
| 23 | cellular response to interferon-beta (GO:0035458) | 4.67006627 |
| 24 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.57301748 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 4.56651459 |
| 26 | positive regulation of interferon-alpha production (GO:0032727) | 4.52519979 |
| 27 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.45060446 |
| 28 | positive regulation of heat generation (GO:0031652) | 4.43248933 |
| 29 | regulation of fever generation (GO:0031620) | 4.40359193 |
| 30 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.34234358 |
| 31 | negative regulation of interleukin-17 production (GO:0032700) | 4.30879222 |
| 32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.30734238 |
| 33 | regulation of interferon-alpha production (GO:0032647) | 4.28779637 |
| 34 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.28671884 |
| 35 | myeloid dendritic cell differentiation (GO:0043011) | 4.25956396 |
| 36 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.25064902 |
| 37 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.23343632 |
| 38 | negative regulation of viral genome replication (GO:0045071) | 4.22065372 |
| 39 | positive regulation of defense response to virus by host (GO:0002230) | 4.15447091 |
| 40 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.13656656 |
| 41 | eosinophil migration (GO:0072677) | 4.13426241 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.05659167 |
| 43 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.05559194 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04470950 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.94910585 |
| 46 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.94577123 |
| 47 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.94577123 |
| 48 | response to interferon-beta (GO:0035456) | 3.93270480 |
| 49 | granulocyte activation (GO:0036230) | 3.92880727 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.91165783 |
| 51 | cellular response to type I interferon (GO:0071357) | 3.91109985 |
| 52 | type I interferon signaling pathway (GO:0060337) | 3.91109985 |
| 53 | regulation of chronic inflammatory response (GO:0002676) | 3.88851170 |
| 54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.87756343 |
| 55 | cellular response to interleukin-15 (GO:0071350) | 3.86011213 |
| 56 | response to type I interferon (GO:0034340) | 3.85744411 |
| 57 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.83629271 |
| 58 | regulation of T cell tolerance induction (GO:0002664) | 3.83395342 |
| 59 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.81922007 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.81848834 |
| 61 | regulation of activation of Janus kinase activity (GO:0010533) | 3.81435419 |
| 62 | respiratory burst (GO:0045730) | 3.80229204 |
| 63 | regulation of mononuclear cell migration (GO:0071675) | 3.79686680 |
| 64 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.77045684 |
| 65 | lymphocyte chemotaxis (GO:0048247) | 3.76588629 |
| 66 | regulation of interleukin-17 production (GO:0032660) | 3.75298390 |
| 67 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.74772755 |
| 68 | regulation of vitamin metabolic process (GO:0030656) | 3.74529323 |
| 69 | T cell migration (GO:0072678) | 3.73509029 |
| 70 | macrophage chemotaxis (GO:0048246) | 3.71298910 |
| 71 | myeloid dendritic cell activation (GO:0001773) | 3.70149715 |
| 72 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.70048944 |
| 73 | superoxide anion generation (GO:0042554) | 3.68064867 |
| 74 | regulation of podosome assembly (GO:0071801) | 3.67325940 |
| 75 | response to protozoan (GO:0001562) | 3.65469672 |
| 76 | positive regulation of type 2 immune response (GO:0002830) | 3.64878585 |
| 77 | monocyte chemotaxis (GO:0002548) | 3.62237404 |
| 78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58789400 |
| 79 | regulation of T cell cytokine production (GO:0002724) | 3.58502151 |
| 80 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.57890709 |
| 81 | reactive oxygen species biosynthetic process (GO:1903409) | 3.57657882 |
| 82 | positive regulation of tolerance induction (GO:0002645) | 3.56697155 |
| 83 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.54425824 |
| 84 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.53894748 |
| 85 | response to host immune response (GO:0052572) | 3.53309281 |
| 86 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.53309281 |
| 87 | response to interleukin-15 (GO:0070672) | 3.50782629 |
| 88 | cellular response to interferon-alpha (GO:0035457) | 3.49063283 |
| 89 | defense response to protozoan (GO:0042832) | 3.46851779 |
| 90 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.44187072 |
| 91 | positive regulation of T cell cytokine production (GO:0002726) | 3.42432200 |
| 92 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.41436725 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.41386302 |
| 94 | negative regulation of amino acid transport (GO:0051956) | 3.41300921 |
| 95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.34839687 |
| 96 | cellular response to nicotine (GO:0071316) | 3.34772900 |
| 97 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.34525794 |
| 98 | positive regulation of chemokine production (GO:0032722) | 3.34139592 |
| 99 | immunoglobulin mediated immune response (GO:0016064) | 3.33923858 |
| 100 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.32217821 |
| 101 | myeloid cell activation involved in immune response (GO:0002275) | 3.31742409 |
| 102 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.31613620 |
| 103 | positive regulation of interferon-beta production (GO:0032728) | 3.31067052 |
| 104 | regulation of growth of symbiont in host (GO:0044126) | 3.30928282 |
| 105 | negative regulation of growth of symbiont in host (GO:0044130) | 3.30928282 |
| 106 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.30928282 |
| 107 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.30928282 |
| 108 | regulation of heat generation (GO:0031650) | 3.30621401 |
| 109 | positive regulation of interleukin-12 production (GO:0032735) | 3.29879176 |
| 110 | positive regulation of B cell mediated immunity (GO:0002714) | 3.28984181 |
| 111 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.28984181 |
| 112 | detection of molecule of bacterial origin (GO:0032490) | 3.28573196 |
| 113 | positive regulation of interleukin-10 production (GO:0032733) | 3.28374360 |
| 114 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.28300663 |
| 115 | microglial cell activation (GO:0001774) | 3.27941098 |
| 116 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.27508417 |
| 117 | neutrophil chemotaxis (GO:0030593) | 3.26369418 |
| 118 | * positive regulation of lymphocyte migration (GO:2000403) | 3.26047779 |
| 119 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.25584620 |
| 120 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.25495100 |
| 121 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.25382913 |
| 122 | regulation of T cell chemotaxis (GO:0010819) | 3.24910797 |
| 123 | positive regulation of T cell chemotaxis (GO:0010820) | 3.24910797 |
| 124 | response to interferon-alpha (GO:0035455) | 3.23955461 |
| 125 | * regulation of lymphocyte chemotaxis (GO:1901623) | 3.23678012 |
| 126 | regulation of cell killing (GO:0031341) | 3.18665107 |
| 127 | regulation of interleukin-12 production (GO:0032655) | 3.18308731 |
| 128 | * negative regulation by host of viral transcription (GO:0043922) | 3.17789104 |
| 129 | negative regulation of interleukin-2 production (GO:0032703) | 3.17771854 |
| 130 | regulation of immunoglobulin secretion (GO:0051023) | 3.17730157 |
| 131 | neutrophil migration (GO:1990266) | 3.17509373 |
| 132 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.17202875 |
| 133 | positive regulation of humoral immune response (GO:0002922) | 3.17111684 |
| 134 | positive regulation of interleukin-17 production (GO:0032740) | 3.15914915 |
| 135 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.15550472 |
| 136 | positive regulation of mast cell degranulation (GO:0043306) | 3.15550472 |
| 137 | regulation of tolerance induction (GO:0002643) | 3.14544582 |
| 138 | * positive regulation of calcium-mediated signaling (GO:0050850) | 3.14000045 |
| 139 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.13842217 |
| 140 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.12211379 |
| 141 | regulation of viral genome replication (GO:0045069) | 3.09251034 |
| 142 | * negative regulation of viral process (GO:0048525) | 3.05700283 |
| 143 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.03291259 |
| 144 | * regulation of lymphocyte migration (GO:2000401) | 3.03013613 |
| 145 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02938437 |
| 146 | germinal center formation (GO:0002467) | 3.01351853 |
| 147 | negative regulation of T cell activation (GO:0050868) | 3.00389279 |
| 148 | positive regulation of cell killing (GO:0031343) | 2.99333416 |
| 149 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98004594 |
| 150 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.95862565 |
| 151 | positive regulation of T cell apoptotic process (GO:0070234) | 2.95423635 |
| 152 | negative regulation of T cell mediated immunity (GO:0002710) | 2.94632726 |
| 153 | negative regulation of cell killing (GO:0031342) | 2.94405478 |
| 154 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94405478 |
| 155 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.91667358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.11943587 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 8.00125859 |
| 3 | * BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.84978255 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.05808449 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.97641201 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.44063498 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.98024698 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.91416824 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.66948680 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.66174538 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.44080972 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06507730 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.93742996 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92581519 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.91727234 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73756491 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.73365504 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58924402 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.09061897 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.03546921 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.91058615 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.85792702 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.82582682 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.78573573 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.77667643 |
| 26 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72796151 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70667951 |
| 28 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68806193 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.67459840 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66208784 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65313387 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64885340 |
| 33 | MAF_26560356_Chip-Seq_TH2_Human | 1.63766531 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55586557 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.53636816 |
| 36 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49836490 |
| 37 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.48349276 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47537137 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46406675 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46289603 |
| 41 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.43488244 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.43467974 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42628030 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41000464 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35275241 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34288247 |
| 47 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33672191 |
| 48 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32313413 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28702010 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26782891 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25332119 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22260442 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21862816 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20400144 |
| 55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18256036 |
| 56 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15942466 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15049118 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14586288 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11474506 |
| 60 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08925164 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08398530 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08321063 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05824918 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05295657 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05295657 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03602453 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02556167 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00973237 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96363260 |
| 70 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95870200 |
| 71 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95414211 |
| 72 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95275838 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94474646 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94466148 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93779572 |
| 76 | MAF_26560356_Chip-Seq_TH1_Human | 0.91044106 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 0.90996947 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87328074 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85656082 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84649057 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83863843 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.83782778 |
| 83 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.83735204 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83534817 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82218072 |
| 86 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.79823309 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79017022 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.79005312 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78487408 |
| 90 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76180228 |
| 91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.75633535 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75307755 |
| 93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.74240129 |
| 94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.72908818 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72596291 |
| 96 | MYC_22102868_ChIP-Seq_BL_Human | 0.71592580 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71574612 |
| 98 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71541321 |
| 99 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70143354 |
| 100 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69619459 |
| 101 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.69266521 |
| 102 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.68609318 |
| 103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.68414564 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68278487 |
| 105 | SA1_27219007_Chip-Seq_Bcells_Human | 0.67195881 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.66790194 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.66214338 |
| 108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.66192383 |
| 109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.65914786 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.65914786 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65744933 |
| 112 | UTX_26944678_Chip-Seq_JUKART_Human | 0.64472986 |
| 113 | GATA3_26560356_Chip-Seq_TH1_Human | 0.64115686 |
| 114 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63633072 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.62065107 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.61956065 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.61099321 |
| 118 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.60947662 |
| 119 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.60120373 |
| 120 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.58703622 |
| 121 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58349442 |
| 122 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.58066838 |
| 123 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.57782339 |
| 124 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.57782339 |
| 125 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.57680158 |
| 126 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.57200908 |
| 127 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.57138235 |
| 128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56180401 |
| 129 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.55754205 |
| 130 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.55497548 |
| 131 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.54865530 |
| 132 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.54397855 |
| 133 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.53453384 |
| 134 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.50939607 |
| 135 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.50580453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 5.33636889 |
| 2 | MP0009785_altered_susceptibility_to | 5.10362515 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.49861557 |
| 4 | MP0003436_decreased_susceptibility_to | 4.43160371 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 4.43083144 |
| 6 | MP0003724_increased_susceptibility_to | 4.18406613 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.79070268 |
| 8 | MP0002419_abnormal_innate_immunity | 3.38640311 |
| 9 | MP0005025_abnormal_response_to | 3.38024858 |
| 10 | MP0005671_abnormal_response_to | 2.95629711 |
| 11 | MP0003303_peritoneal_inflammation | 2.95322599 |
| 12 | MP0009764_decreased_sensitivity_to | 2.72498276 |
| 13 | MP0002723_abnormal_immune_serum | 2.65534411 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.58415901 |
| 15 | MP0001800_abnormal_humoral_immune | 2.45874111 |
| 16 | MP0001533_abnormal_skeleton_physiology | 2.44570488 |
| 17 | MP0001853_heart_inflammation | 2.36807228 |
| 18 | MP0002006_tumorigenesis | 2.35711999 |
| 19 | MP0004947_skin_inflammation | 2.25694186 |
| 20 | MP0001790_abnormal_immune_system | 2.20947813 |
| 21 | MP0005387_immune_system_phenotype | 2.20947813 |
| 22 | MP0001819_abnormal_immune_cell | 2.17635503 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.14698006 |
| 24 | MP0000685_abnormal_immune_system | 2.10217445 |
| 25 | MP0004510_myositis | 2.10121901 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.05078696 |
| 27 | MP0008469_abnormal_protein_level | 1.98351851 |
| 28 | MP0002405_respiratory_system_inflammati | 1.96310860 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.95598761 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.91607812 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.87116228 |
| 32 | MP0003448_altered_tumor_morphology | 1.85942508 |
| 33 | MP0003075_altered_response_to | 1.83612359 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.80257186 |
| 35 | MP0000343_altered_response_to | 1.65122936 |
| 36 | MP0005166_decreased_susceptibility_to | 1.62311834 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.58836190 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.56408417 |
| 39 | MP0003186_abnormal_redox_activity | 1.54208726 |
| 40 | MP0000858_altered_metastatic_potential | 1.52228842 |
| 41 | MP0009278_abnormal_bone_marrow | 1.52145220 |
| 42 | MP0003690_abnormal_glial_cell | 1.49987867 |
| 43 | MP0000716_abnormal_immune_system | 1.45824741 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.45624335 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.41807907 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.41303642 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.38690667 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.34312752 |
| 49 | MP0002398_abnormal_bone_marrow | 1.31295316 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.25914103 |
| 51 | MP0005164_abnormal_response_to | 1.25812888 |
| 52 | MP0003195_calcinosis | 1.24063106 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.23006208 |
| 54 | MP0005310_abnormal_salivary_gland | 1.17452606 |
| 55 | MP0005390_skeleton_phenotype | 1.16232936 |
| 56 | MP0002933_joint_inflammation | 1.16023428 |
| 57 | MP0002429_abnormal_blood_cell | 1.15451383 |
| 58 | MP0003828_pulmonary_edema | 1.13925460 |
| 59 | MP0000604_amyloidosis | 1.08552365 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.05316966 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.04618060 |
| 62 | MP0006054_spinal_hemorrhage | 1.02229566 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.01605532 |
| 64 | MP0009763_increased_sensitivity_to | 1.01221643 |
| 65 | MP0008004_abnormal_stomach_pH | 1.01186182 |
| 66 | MP0002722_abnormal_immune_system | 0.97602141 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 0.95341597 |
| 68 | MP0001545_abnormal_hematopoietic_system | 0.95341597 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.95064598 |
| 70 | MP0005451_abnormal_body_composition | 0.87604097 |
| 71 | MP0001851_eye_inflammation | 0.86884901 |
| 72 | MP0002332_abnormal_exercise_endurance | 0.85157645 |
| 73 | MP0010307_abnormal_tumor_latency | 0.84135448 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.83754084 |
| 75 | MP0001501_abnormal_sleep_pattern | 0.82840905 |
| 76 | MP0009840_abnormal_foam_cell | 0.81772497 |
| 77 | MP0000920_abnormal_myelination | 0.80565033 |
| 78 | MP0003646_muscle_fatigue | 0.79563144 |
| 79 | MP0004883_abnormal_blood_vessel | 0.77438151 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.76976116 |
| 81 | MP0005535_abnormal_body_temperature | 0.75099413 |
| 82 | MP0004742_abnormal_vestibular_system | 0.72230583 |
| 83 | MP0002163_abnormal_gland_morphology | 0.68664159 |
| 84 | MP0000249_abnormal_blood_vessel | 0.68506168 |
| 85 | MP0001919_abnormal_reproductive_system | 0.66847504 |
| 86 | MP0005165_increased_susceptibility_to | 0.63358198 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.63208525 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.60735870 |
| 89 | MP0001542_abnormal_bone_strength | 0.59751070 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.57267336 |
| 91 | MP0001958_emphysema | 0.57205227 |
| 92 | MP0001873_stomach_inflammation | 0.56975008 |
| 93 | MP0004381_abnormal_hair_follicle | 0.56835262 |
| 94 | MP0003795_abnormal_bone_structure | 0.54287242 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.53748198 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.53714467 |
| 97 | MP0001727_abnormal_embryo_implantation | 0.53417894 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.51205475 |
| 99 | MP0001663_abnormal_digestive_system | 0.50876505 |
| 100 | MP0002090_abnormal_vision | 0.49030904 |
| 101 | MP0005647_abnormal_sex_gland | 0.47851255 |
| 102 | MP0002254_reproductive_system_inflammat | 0.47723404 |
| 103 | MP0005408_hypopigmentation | 0.47546081 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.46285323 |
| 105 | MP0008260_abnormal_autophagy | 0.45524858 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.45318893 |
| 107 | MP0008873_increased_physiological_sensi | 0.43878014 |
| 108 | MP0010352_gastrointestinal_tract_polyps | 0.43056386 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.43002155 |
| 110 | MP0005171_absent_coat_pigmentation | 0.40237786 |
| 111 | MP0000371_diluted_coat_color | 0.39672526 |
| 112 | MP0000609_abnormal_liver_physiology | 0.37509863 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.35210515 |
| 114 | MP0000490_abnormal_crypts_of | 0.34698033 |
| 115 | MP0003045_fibrosis | 0.34202508 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34062965 |
| 117 | MP0003866_abnormal_defecation | 0.32811359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.69993817 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.27214158 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.92032618 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.79979037 |
| 5 | Stomatitis (HP:0010280) | 6.48654787 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.03611744 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.75077849 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.53849336 |
| 9 | Abnormality of macrophages (HP:0004311) | 5.18009130 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.47116969 |
| 11 | Optic neuritis (HP:0100653) | 4.47116969 |
| 12 | Interstitial pulmonary disease (HP:0006530) | 4.36759575 |
| 13 | Orchitis (HP:0100796) | 4.36655697 |
| 14 | Myositis (HP:0100614) | 4.28369854 |
| 15 | Gingivitis (HP:0000230) | 4.25306120 |
| 16 | Recurrent skin infections (HP:0001581) | 4.20873468 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 4.17841116 |
| 18 | Abnormality of T cells (HP:0002843) | 4.10172520 |
| 19 | Basal ganglia calcification (HP:0002135) | 4.10066244 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.00631292 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.89051475 |
| 22 | Obstructive lung disease (HP:0006536) | 3.89051475 |
| 23 | Vasculitis (HP:0002633) | 3.84316919 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.75889579 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.64146098 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 3.61405917 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 3.53313164 |
| 28 | Encephalitis (HP:0002383) | 3.53236095 |
| 29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.51800154 |
| 30 | Recurrent bronchitis (HP:0002837) | 3.45421262 |
| 31 | Increased IgM level (HP:0003496) | 3.42651093 |
| 32 | Axonal loss (HP:0003447) | 3.37045773 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.23677527 |
| 34 | Petechiae (HP:0000967) | 3.22008908 |
| 35 | Poor head control (HP:0002421) | 3.21485287 |
| 36 | Abnormality of eosinophils (HP:0001879) | 3.18529158 |
| 37 | Recurrent viral infections (HP:0004429) | 3.17879222 |
| 38 | IgG deficiency (HP:0004315) | 3.06137728 |
| 39 | Severe combined immunodeficiency (HP:0004430) | 3.05891652 |
| 40 | Purpura (HP:0000979) | 2.99544819 |
| 41 | Disinhibition (HP:0000734) | 2.97576799 |
| 42 | Eosinophilia (HP:0001880) | 2.92541516 |
| 43 | Hepatosplenomegaly (HP:0001433) | 2.88273861 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.86132953 |
| 45 | Nausea (HP:0002018) | 2.84676561 |
| 46 | Pustule (HP:0200039) | 2.81988047 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81413188 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81413188 |
| 49 | Urticaria (HP:0001025) | 2.80859821 |
| 50 | Glomerulonephritis (HP:0000099) | 2.78243345 |
| 51 | Prostate neoplasm (HP:0100787) | 2.76264930 |
| 52 | Hemorrhage of the eye (HP:0011885) | 2.72966500 |
| 53 | Abnormality of the pericardium (HP:0001697) | 2.71749425 |
| 54 | Periodontitis (HP:0000704) | 2.71056581 |
| 55 | Joint swelling (HP:0001386) | 2.69951889 |
| 56 | Aplastic anemia (HP:0001915) | 2.69939917 |
| 57 | Thick nail (HP:0001805) | 2.69374499 |
| 58 | Recurrent pneumonia (HP:0006532) | 2.67752737 |
| 59 | Porencephaly (HP:0002132) | 2.66606811 |
| 60 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.66120831 |
| 61 | Joint hemorrhage (HP:0005261) | 2.63722999 |
| 62 | Cellulitis (HP:0100658) | 2.63355847 |
| 63 | Meningitis (HP:0001287) | 2.61920771 |
| 64 | Nephritis (HP:0000123) | 2.60662953 |
| 65 | Polyneuropathy (HP:0001271) | 2.60404571 |
| 66 | Prolonged neonatal jaundice (HP:0006579) | 2.58403190 |
| 67 | Increased serum ferritin (HP:0003281) | 2.57955108 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.53802393 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.53526878 |
| 70 | Agnosia (HP:0010524) | 2.51402241 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51003582 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51003582 |
| 73 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51003582 |
| 74 | Gingival bleeding (HP:0000225) | 2.50002878 |
| 75 | Tetraparesis (HP:0002273) | 2.49789824 |
| 76 | Thyroiditis (HP:0100646) | 2.48415829 |
| 77 | Granulocytopenia (HP:0001913) | 2.48118500 |
| 78 | Arterial thrombosis (HP:0004420) | 2.47794075 |
| 79 | Mutism (HP:0002300) | 2.44186677 |
| 80 | Abnormality of T cell physiology (HP:0011840) | 2.43926144 |
| 81 | Hypoproteinemia (HP:0003075) | 2.42825247 |
| 82 | Abnormality of the pleura (HP:0002103) | 2.40268554 |
| 83 | Pulmonary embolism (HP:0002204) | 2.39631410 |
| 84 | IgA deficiency (HP:0002720) | 2.37981205 |
| 85 | Alveolar cell carcinoma (HP:0006519) | 2.35801582 |
| 86 | Fused cervical vertebrae (HP:0002949) | 2.34065583 |
| 87 | Abnormality of T cell number (HP:0011839) | 2.32465172 |
| 88 | Hemoptysis (HP:0002105) | 2.31591078 |
| 89 | Recurrent lower respiratory tract infections (HP:0002783) | 2.31179697 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.30551262 |
| 91 | Lymphopenia (HP:0001888) | 2.30115714 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.27102297 |
| 93 | Chronic otitis media (HP:0000389) | 2.23431062 |
| 94 | Lower limb hyperreflexia (HP:0002395) | 2.22245905 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21384591 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21384591 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21384591 |
| 98 | T lymphocytopenia (HP:0005403) | 2.20523277 |
| 99 | Abnormality of B cell number (HP:0010975) | 2.20427948 |
| 100 | Arthralgia (HP:0002829) | 2.19141567 |
| 101 | Pigmentary retinal degeneration (HP:0001146) | 2.17933494 |
| 102 | Glomerulopathy (HP:0100820) | 2.17710086 |
| 103 | Premature loss of primary teeth (HP:0006323) | 2.17344041 |
| 104 | Leukocytosis (HP:0001974) | 2.16870724 |
| 105 | Loss of speech (HP:0002371) | 2.16384299 |
| 106 | Agammaglobulinemia (HP:0004432) | 2.16366394 |
| 107 | Osteomyelitis (HP:0002754) | 2.15521898 |
| 108 | B lymphocytopenia (HP:0010976) | 2.13322695 |
| 109 | Progressive visual loss (HP:0000529) | 2.11390497 |
| 110 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10394345 |
| 111 | Oral leukoplakia (HP:0002745) | 2.09470421 |
| 112 | Bone pain (HP:0002653) | 2.07323570 |
| 113 | Chest pain (HP:0100749) | 2.04822759 |
| 114 | Autoimmune hemolytic anemia (HP:0001890) | 2.04562916 |
| 115 | Cleft eyelid (HP:0000625) | 2.03997894 |
| 116 | Anorexia (HP:0002039) | 2.03580232 |
| 117 | Chronic diarrhea (HP:0002028) | 2.03468667 |
| 118 | Acute hepatic failure (HP:0006554) | 2.03165414 |
| 119 | Abnormality of iron homeostasis (HP:0011031) | 1.96815746 |
| 120 | Parakeratosis (HP:0001036) | 1.96505280 |
| 121 | Lymphoma (HP:0002665) | 1.94634426 |
| 122 | Abnormality of the prostate (HP:0008775) | 1.94342149 |
| 123 | Bronchitis (HP:0012387) | 1.93420368 |
| 124 | Myocardial infarction (HP:0001658) | 1.93108381 |
| 125 | Episodic fever (HP:0001954) | 1.92878730 |
| 126 | Gangrene (HP:0100758) | 1.92417580 |
| 127 | Gastrointestinal infarctions (HP:0005244) | 1.92207748 |
| 128 | Dysostosis multiplex (HP:0000943) | 1.92176924 |
| 129 | Pathologic fracture (HP:0002756) | 1.90065290 |
| 130 | Pulmonary fibrosis (HP:0002206) | 1.89018702 |
| 131 | Mucopolysacchariduria (HP:0008155) | 1.87216131 |
| 132 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87216131 |
| 133 | Abnormality of the basal ganglia (HP:0002134) | 1.86672241 |
| 134 | Nasal polyposis (HP:0100582) | 1.85998931 |
| 135 | Upper motor neuron abnormality (HP:0002127) | 1.84790608 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.84674185 |
| 137 | Memory impairment (HP:0002354) | 1.83638313 |
| 138 | Skin ulcer (HP:0200042) | 1.78434975 |
| 139 | Neoplasm of head and neck (HP:0012288) | 1.77087041 |
| 140 | Esophageal neoplasm (HP:0100751) | 1.77087041 |
| 141 | Micronodular cirrhosis (HP:0001413) | 1.74236093 |
| 142 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73710877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.31779813 |
| 2 | PBK | 5.22869759 |
| 3 | RIPK4 | 4.21519706 |
| 4 | MAP3K14 | 4.01972773 |
| 5 | TXK | 3.87841250 |
| 6 | TBK1 | 3.82174556 |
| 7 | IRAK3 | 2.95562457 |
| 8 | IRAK4 | 2.89297452 |
| 9 | MAP4K1 | 2.70345793 |
| 10 | IKBKE | 2.55867774 |
| 11 | IKBKB | 2.55451178 |
| 12 | TAOK2 | 2.46479266 |
| 13 | PIM2 | 2.28211301 |
| 14 | TYK2 | 2.13834575 |
| 15 | KDR | 2.11847342 |
| 16 | BMPR2 | 2.08235253 |
| 17 | JAK3 | 1.96090286 |
| 18 | MST4 | 1.80699741 |
| 19 | CSK | 1.80240856 |
| 20 | KIT | 1.73374656 |
| 21 | TAOK3 | 1.71850155 |
| 22 | MAP3K3 | 1.71759905 |
| 23 | DDR2 | 1.68141473 |
| 24 | ERN1 | 1.67975263 |
| 25 | JAK1 | 1.60848716 |
| 26 | ZAP70 | 1.59931871 |
| 27 | MAP3K12 | 1.54211261 |
| 28 | TAOK1 | 1.53510697 |
| 29 | FGR | 1.51194267 |
| 30 | BMX | 1.47950632 |
| 31 | MAP3K13 | 1.43366181 |
| 32 | CHUK | 1.37294305 |
| 33 | LYN | 1.34587685 |
| 34 | TYRO3 | 1.32185969 |
| 35 | SYK | 1.31542746 |
| 36 | NME2 | 1.28987312 |
| 37 | ABL2 | 1.28611845 |
| 38 | MST1R | 1.25868734 |
| 39 | EIF2AK2 | 1.23346908 |
| 40 | GRK7 | 1.19664646 |
| 41 | HCK | 1.16595315 |
| 42 | MATK | 1.09859014 |
| 43 | LCK | 1.08643057 |
| 44 | ADRBK2 | 1.07543291 |
| 45 | IRAK2 | 1.06365136 |
| 46 | MAP3K5 | 1.03925377 |
| 47 | MAP2K3 | 1.03891852 |
| 48 | MUSK | 1.01193372 |
| 49 | BUB1 | 0.97923681 |
| 50 | PIM1 | 0.95616976 |
| 51 | CSF1R | 0.92722097 |
| 52 | BTK | 0.91770364 |
| 53 | MAP2K6 | 0.90486583 |
| 54 | IRAK1 | 0.88938317 |
| 55 | FES | 0.88936594 |
| 56 | PRKCD | 0.87427582 |
| 57 | STK10 | 0.85844189 |
| 58 | MARK3 | 0.84383108 |
| 59 | TEC | 0.81294317 |
| 60 | SCYL2 | 0.78961709 |
| 61 | TGFBR2 | 0.78106856 |
| 62 | ARAF | 0.77169161 |
| 63 | YES1 | 0.76799646 |
| 64 | SIK3 | 0.76353149 |
| 65 | RPS6KA4 | 0.75845868 |
| 66 | NEK9 | 0.74880718 |
| 67 | ERBB3 | 0.74473532 |
| 68 | JAK2 | 0.74128851 |
| 69 | TESK2 | 0.73334445 |
| 70 | ERBB4 | 0.73245717 |
| 71 | STK4 | 0.71641404 |
| 72 | TNK2 | 0.66220704 |
| 73 | ABL1 | 0.60193436 |
| 74 | ITK | 0.59542228 |
| 75 | EPHB1 | 0.58405511 |
| 76 | MAPKAPK3 | 0.56130239 |
| 77 | BMPR1B | 0.51829309 |
| 78 | EGFR | 0.50681030 |
| 79 | HIPK2 | 0.50501894 |
| 80 | EIF2AK3 | 0.49994086 |
| 81 | CAMKK2 | 0.49431272 |
| 82 | CLK1 | 0.48644534 |
| 83 | PRKCQ | 0.44353794 |
| 84 | DAPK3 | 0.44267337 |
| 85 | CDC42BPA | 0.43475688 |
| 86 | ALK | 0.42805150 |
| 87 | TRPM7 | 0.42494320 |
| 88 | FYN | 0.42022736 |
| 89 | BCKDK | 0.39314569 |
| 90 | MOS | 0.38882463 |
| 91 | TESK1 | 0.38596122 |
| 92 | ADRBK1 | 0.38144776 |
| 93 | PIK3CG | 0.37748761 |
| 94 | ACVR1B | 0.35950968 |
| 95 | WNK4 | 0.34955506 |
| 96 | IGF1R | 0.31284557 |
| 97 | DAPK2 | 0.27600150 |
| 98 | INSR | 0.27588753 |
| 99 | FGFR4 | 0.26992799 |
| 100 | PIK3CA | 0.26685976 |
| 101 | SIK2 | 0.25986886 |
| 102 | DYRK3 | 0.25641157 |
| 103 | LRRK2 | 0.25175051 |
| 104 | MAP3K11 | 0.24994606 |
| 105 | PDK1 | 0.22533857 |
| 106 | FGFR1 | 0.21145186 |
| 107 | MAP3K1 | 0.19933824 |
| 108 | TSSK6 | 0.18585397 |
| 109 | FGFR3 | 0.17941902 |
| 110 | RIPK1 | 0.17858473 |
| 111 | MAPK11 | 0.17707815 |
| 112 | RPS6KA1 | 0.16206611 |
| 113 | PRKCH | 0.15852766 |
| 114 | DAPK1 | 0.15743043 |
| 115 | RPS6KA5 | 0.15563119 |
| 116 | STK3 | 0.15466255 |
| 117 | MAP3K8 | 0.15410942 |
| 118 | SRPK1 | 0.14677393 |
| 119 | MAPKAPK2 | 0.14498036 |
| 120 | PDPK1 | 0.14041124 |
| 121 | PLK2 | 0.12551130 |
| 122 | SRC | 0.11426113 |
| 123 | PKN1 | 0.11043205 |
| 124 | EPHA3 | 0.08280735 |
| 125 | PRKG2 | 0.08248280 |
| 126 | PDGFRB | 0.07851726 |
| 127 | MYLK | 0.06217926 |
| 128 | MAPK4 | 0.05953562 |
| 129 | NLK | 0.05796261 |
| 130 | GRK6 | 0.05779080 |
| 131 | PRKCE | 0.05492677 |
| 132 | PRKACG | 0.04838028 |
| 133 | PRKCA | 0.04135445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.75610856 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.06184529 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.46589648 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.36424225 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.03809572 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.99414589 |
| 7 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.93585100 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.91144870 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.73633644 |
| 10 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.72590840 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.55844955 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.44708101 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.40590209 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.36237340 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.32253043 |
| 16 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31349032 |
| 17 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.14208724 |
| 18 | * Salmonella infection_Homo sapiens_hsa05132 | 2.13733725 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 2.13435557 |
| 20 | Measles_Homo sapiens_hsa05162 | 2.01384786 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94451009 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.89150481 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79376212 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.76397790 |
| 25 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.70990324 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.57407825 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52210922 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41958489 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40228060 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.39969986 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38870492 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.28534802 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18500819 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.18066331 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14179107 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10093631 |
| 37 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08855874 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 1.08717094 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91158814 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90765138 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90480157 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 0.87835924 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 0.83923790 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81871987 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.80338546 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74705288 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73243555 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72109312 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.69702596 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61649933 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59843425 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58009842 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55831696 |
| 54 | Proteasome_Homo sapiens_hsa03050 | 0.51992282 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50585950 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.50459903 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.49280276 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49132376 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47110328 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46124316 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40901218 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40584023 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40292275 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40065835 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38449341 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37860380 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33755315 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.33462750 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31931605 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28617320 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27842340 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26657338 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.25490806 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25066927 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22726059 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.19962883 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.19738787 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18660794 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17350607 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.16830300 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16088517 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14567871 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13529149 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.12620501 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.10180857 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.06946277 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.06526284 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.05943742 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.05930632 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.05714896 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.04735956 |
| 92 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.03865508 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.03569641 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.03401099 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.02160505 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.01741813 |
| 97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.01711968 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.01335140 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.00306518 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | -0.0501964 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0456445 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0430520 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0424664 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | -0.0413491 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | -0.0388986 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0333001 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | -0.0325261 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | -0.0276314 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | -0.0191601 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0190594 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0168513 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | -0.0166620 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0111672 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0109189 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0106226 |
| 116 | RNA polymerase_Homo sapiens_hsa03020 | -0.0055406 |

